HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Petition Requests Skin Treatment GRASE For Ophthalmic Monograph Ingredient

This article was originally published in The Tan Sheet

Executive Summary

A beauty professional says an eye redness reliever containing tetrahydrozoline hydrochloride – included in FDA’s OTC monograph for ophthalmic drug products – safely and effectively controls redness from acne and other skin ailments. She requests adding the ingredient to the skin protectant drug monograph.

You may also be interested in...



FDA Encourages Novel Switch Ideas, Though NSURE Remains Unsure

Rx-to-OTC switch sponsors should not wait for FDA to act on NSURE before proposing innovative switch solutions, because reviewers are open to discussing ideas now, an agency official says. Some experts predict the new switch paradigm will not yield concrete regulatory changes, and are promoting other ways to expand OTC access.

NSF Leaders On How New Cosmetics Certification Could Bolster MoCRA Compliance

NSF’s Contents and Claims Certified Guideline for beauty and personal-care products should position companies well for compliance with new US regulations under the Modernization of Cosmetic Regulations Act, the organization says. NSF senior leaders discuss in an interview with HBW Insight.

‘The Party Is Over': Green Claims Requirements Among Many Regulatory Changes Coming To EU Cosmetics

Biorius CEO Frédéric Lebreux provided updates on EU Green Deal initiatives including revision of the Cosmetic Products Regulation, as well as regulations in development for green claims and ecodesign, at the Independent Beauty Association’s virtual Technical/Regulatory Forum.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123421

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel